Stock XXY CROSS COUNTRY HEALTHCARE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cross Country Healthcare, Inc. Deutsche Boerse AG

Equities

XXY

US2274831047

Market Closed - Deutsche Boerse AG
Other stock markets
 01:19:52 03/07/2024 am IST 		5-day change 1st Jan Change
12.6 EUR -1.56% Intraday chart for Cross Country Healthcare, Inc. -2.33% -38.24%
06/05 Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating MT
01/05 (CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20 MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating
MT
Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating
MT
UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating
MT
Truist Adjusts Cross Country Healthcare's Price Target to $16 From $22, Keeps Hold Rating
MT
JMP Securities Initiates Cross Country Healthcare With Market Perform Rating
MT
UBS Initiates Coverage on Cross Country Healthcare With Neutral Rating, $22 Price Target
MT
Barrington Cuts Price Target on Cross Country Healthcare to $26 From $29, Keeps Outperform Rating
MT
Jefferies Downgrades Cross Country Healthcare to Hold From Buy, Adjusts Price Target to $21 From $32
MT
Barrington Cuts Price Target on Cross Country Healthcare to $29 From $35 Amid Reduction in Estimates, Keeps at Outperform
MT
Credit Suisse Adjusts Cross Country Healthcare's Price Target to $26 From $27, Keeps Neutral Rating
MT
William Blair Initiates Cross Country Healthcare at Outperform Rating
MT
Barrington Research Cuts Cross Country Healthcare's Price Target to $35 From $42, Maintains Outperform Rating
MT
Credit Suisse Lowers Cross Country Healthcare's Price Target to $27 From $32, Keeps Neutral Rating
MT
Truist Securities Adjusts Cross Country Healthcare Price Target to $25 From $38, Maintains Hold Rating
MT
Loop Capital Initiates Cross Country Healthcare at Buy Rating With $30 Price Target
MT
Barrington Trims Price Target on Cross Country Healthcare to $42 From $45, Reiterates Outperform Rating
MT
Benchmark Capital Adjusts Cross Country Healthcare Price Target to $40 From $45, Maintains Buy Rating
MT
Credit Suisse Lifts Cross Country Healthcare's Price Target to $32 From $31 After Higher-Than-Expected Q4 Results, Keeps Neutral Rating
MT
Barrington Raises Price Target on Cross Country Healthcare to $45 From $41, Affirms Outperform Rating
MT
Truist Securities Downgrades Cross Country Healthcare to Hold From Buy; Price Target is $36
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CCRN Stock
  4. XXY Stock
  5. News Cross Country Healthcare, Inc.
  6. Analyst Reco.